新经济股升幅跑赢大市 阿里/小米/平安好医生/阅文/众安升3%-6%
内地「武肺」疫情确诊个案突破2万宗，达20,438人，死亡人数增至425宗。人民币兑美元中间价今天继续大幅下调530点子，报6.9779，为去年12月30日以来最低，跌幅更为逾年半最大。不过，人行连续第二天采取行动改善流动性，承昨天长假後展开历来最多单日达1.2万亿人民币逆回购操後，今天再进行共5,000亿人民币逆回购操作。沪指及深成继昨天长假後复市追跌外围续挫7.7%-8.4%後，今天低开2.2%及2.1%分别报2,685及9,578获承接，掉头最多倒升0.9及2.5%，高见2,772及10,022遇压，现造2,738及9,880，仅跌0.3%及倒升1%。
本港新经济股全面跑赢大市，尤其是众安在线(06060.HK)及阅文(00772.HK)三连弹，前者股价高见27.55元，受制10天线(27.7元)，现造27.3元，续升6%；後者股价重越牛熊线、50天及10天线(33元/33.48/34.06元)，最高见34.5元，现造33.9元，续涨3.7%。
阿里巴巴(09988.HK)两连弹，股价曾重越10天线(210.8元)，最高见211.6元，现造211元，续弹2.9%。美团点评(03690.HK)三连弹，最高见102.7元(受制10天线102.8元)，现造101.5元，续弹2%。小米(01810.HK)两连弹，股价曾一举重越20天及10天线(12.2元及12.7元)，最高见12.8元，现造12.42元，续弹3.3%。蓝筹腾讯(00700.HK)曾一举重越10天及20天线(384.1元及388.9元)，最高见390.4元，现造386元，续弹1.6%。
平安好医生(01833.HK)继昨天整固後，今早股价重越10天线(68.8元)，最高见70.3元，现造68.45元，回升3.4%；阿里健康(00241.HK)扭转由逾四年半高位连吐三天势，股价重越10天线(10.71元)，最高见11.2元，现造10.98元，回升4.8%。
雷蛇(01337.HK)及易鑫(02858.HK)高见1.27元及1.66元，现造1.26元及1.64元，回升2.4%及1.2%；美图(01357.HK)三连弹，最高见1.64元，受制百天及10天线(1.67元)，现造1.6元，续升1.9%。
本港去年末季经济按年收缩略扩至2.9%，按季续降0.4%(前值转降3%)，全年GDP收缩1.2%为十年来首见。港股继昨天扭过去三天累挫近5.9%颓势反覆微弹不足0.2%後，今早高开134点或0.5%，升幅曾扩至371点或1.4%高见26,728遇阻，现造26,515，续弹158点或0.6%；国指高见10,429，现造10,363，续弹0.9%；总成交额611亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
